| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 305.4K | $2.54M | - | |
| CFO | 215.4K | $1.79M | - | |
| Dir | 119.9K | $998.4K | - | |
| VP | 104.1K | $867.2K | - | |
| Dir | 89.0K | $741.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 26, 2020 | Zoon Kathryn C62 | Director | Sell | 4,093 | $85.10 | $348,322.08 | -23.3% | |
| May 12, 2020 | Zoon Kathryn C62 | Director | Sell | 1,660 | $85.21 | $141,454.24 | -10.1% | |
| May 11, 2020 | Joulwan George A | Director | Sell | 2,000 | $85.19 | $170,371.20 | -6.3% | |
| May 11, 2020 | Harsanyi Zsolt | Director | Sell | 4,940 | $81.99 | $405,024.67 | -16.5% | |
| May 5, 2020 | Richard Ronald | Director | Sell | 8,375 | $80.19 | $671,628.94 | -51.1% | |
| Apr 30, 2020 | El-Hibri Fuad | Chairman | Sell | 40,000 | $74.13 | $2,965,000.00 | -1.6% | |
| Apr 27, 2020 | Richard Ronald | Director | Sale+OE | 7,893 | $78.00 | $615,654.00 | -32.5% | |
| Apr 23, 2020 | El-Hibri Fuad | Chairman | Sell | 40,000 | $67.65 | $2,706,000.00 | -1.5% | |
| Apr 20, 2020 | Havey Adam | EVP, Business Operations | Sale+OE | 37,423 | $66.82 | $2,500,531.00 | -35.3% | |
| Apr 16, 2020 | El-Hibri Fuad | Chairman | Sell | 20,000 | $62.47 | $1,249,400.00 | -1.5% |